342 related articles for article (PubMed ID: 33558238)
1. Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.
Moisan F; Oucherif S; Kaulanjan-Checkmodine P; Prey S; Rousseau B; Bonneu M; Claverol S; Gontier E; Lacomme S; Dousset L; Couffinhal T; Toutain J; Loot M; Cario-André M; Jullié ML; Léauté-Labrèze C; Taieb A; Rezvani HR
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33558238
[TBL] [Abstract][Full Text] [Related]
2. Is Infantile Hemangioma a Neuroendocrine Tumor?
Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552
[TBL] [Abstract][Full Text] [Related]
3. β-Adrenoceptor Blockade for Infantile Hemangioma Therapy: Do β3-Adrenoceptors Play a Role?
Escarcega González CE; González Hernández A; Villalón CM; Rodríguez MG; Marichal Cancino BA
J Vasc Res; 2018; 55(3):159-168. PubMed ID: 29936502
[TBL] [Abstract][Full Text] [Related]
4. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
Pan WK; Li P; Guo ZT; Huang Q; Gao Y
Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of infantile hemangiomas treated with propranolol.
Bagazgoitia L; Hernández-Martín Á; Torrelo A
Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
7. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
8. Salivary levels of angiopoietin-2 in infants with infantile haemangiomas treated with and without systemic propranolol.
Seamens A; Nieman E; Losavio K; Bradley B; Nelson K; Chen KH; Chen S; Arbiser J; Lawley LP
Exp Dermatol; 2018 Jun; 27(6):636-640. PubMed ID: 29427463
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
[TBL] [Abstract][Full Text] [Related]
10. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
[TBL] [Abstract][Full Text] [Related]
11. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
12. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
13. Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).
Janmohamed SR; Madern GC; de Laat PC; Oranje AP
Eur J Pediatr; 2015 Jan; 174(1):97-103. PubMed ID: 25156689
[TBL] [Abstract][Full Text] [Related]
14. Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas.
Prey S; Leaute-Labreze C; Pain C; Moisan F; Vergnes P; Loot M; Taieb A; Cario-Andre M
Histopathology; 2014 Sep; 65(3):436-9. PubMed ID: 24666350
[No Abstract] [Full Text] [Related]
15. β1-Adrenoceptor mRNA level reveals distinctions between infantile hemangioma and vascular malformations.
Rössler J; Haubold M; Gilsbach R; Jüttner E; Schmitt D; Niemeyer CM; Hein L
Pediatr Res; 2013 Apr; 73(4 Pt 1):409-13. PubMed ID: 23370410
[TBL] [Abstract][Full Text] [Related]
16. Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Lee JC; Modiri O; England RW; Shawber CJ; Wu JK
Plast Reconstr Surg; 2021 Apr; 147(4):875-885. PubMed ID: 33776033
[TBL] [Abstract][Full Text] [Related]
17. Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study.
Bertrand J; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Powell J
Pediatr Dermatol; 2011; 28(6):649-654. PubMed ID: 21995756
[TBL] [Abstract][Full Text] [Related]
18. Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.
Zhang L; Mai HM; Zheng J; Zheng JW; Wang YA; Qin ZP; Li KL
Int J Clin Exp Pathol; 2014; 7(1):48-55. PubMed ID: 24427325
[TBL] [Abstract][Full Text] [Related]
19. Propranolol targets the contractility of infantile haemangioma-derived pericytes.
Lee D; Boscolo E; Durham JT; Mulliken JB; Herman IM; Bischoff J
Br J Dermatol; 2014 Nov; 171(5):1129-37. PubMed ID: 24720697
[TBL] [Abstract][Full Text] [Related]
20. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
